Unibest
← Back to patent-cliff list

CAS 14244-64-5

Codes: OXALI-008, OXALI-009

Application context (from source-drug indications)

Intestinal neoplasmOxaliplatinGastric cancerOxaliplatinPancreatic cancerOxaliplatinColorectal cancerOxaliplatinColon cancerOxaliplatinBreast cancerOxaliplatin

Source drugs (routes using this intermediate)

DrugTierExpiry
OxaliplatinTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

OxaliplatinOptimised routesteps: 2total yield: 2.9 g
(1R,2R)-cyclohexane-1,2-diamine→OXALI-007→OXALI-008→OXALI-009

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.